Opinion
Will State Marijuana Operators Get a Federal Green Light Before DEA Resolves MMJ's Seven-Year Wait?
"One DEA Schedule I laboratory registration approved. FDA INDs granted. Orphan Drug Designation awarded. Yet the cultivation application remains unresolved as patients continue to wait. This is ...
"After Eight Years, Millions invested, FDA INDs, Orphan Drug Designation, DEA Inspections, and a Completed Federal Investigation, MMJ Demands the Government Explain Why Companies That Followed Federal ...
With reference to the Company's press release on May 28, 2026, regarding the decision to conduct a rights issue in combination with a loan, Cantargia AB (Publ) ("Cantargia" or the "Company") invites ...
The global biopharmaceuticals market is projected to grow at a compound annual growth rate (CAGR) of approximately 12% over ...
Facial plastic surgeon explains how technique, tissue quality, and healing timelines influence facelift outcomes beyond social media speculation. CHEVY CHASE, MD AND WASHINGTON, DC / ACCESS Newswire / ...
The global electrophysiology market, valued at $6.7 billion in 2021, is projected to grow at a rate of 12% over the next five ...
Crofelemer delayed-release tablets are Jaguar's FDA-approved prescription drug under botanical guidance ("botanical drug") derived from the Croton lechleri tree. Crofelemer, in a novel liquid ...
"As SAM (Smart Approaches To Marijuana) and MMJ International Holdings Prepare an Appeal, Medicare Doctors Now Stand Between Seniors and Uncharacterized, Unsafe Hemp Products," stated Duane Boise, CEO ...
BusinessRate recognition reflects consistently positive patient feedback and trusted facial plastic surgery care in Irvine and throughout Orange County. IRVINE, CA / ACCESS Newswire / May 28, 2026 / ...
Company discusses AI-assisted body-map monitoring architecture and long-term imaging technology development initiatives MESA, AZ / ACCESS Newswire / May 28, 2026 / Medical Care Technologies Inc. (OTC ...
Global nonprofit strengthens leadership with expertise spanning government, medicine, and international healthcare systems in pursuit of zero preventable patient harm IRVINE, CA / ACCESS Newswire / ...
FORT LAUDERDALE, FL / ACCESS Newswire / May 28, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results